Literature DB >> 2926259

Tensa retraction cholesteatoma: treatment and long-term results.

T Lau1, M Tos.   

Abstract

To obtain the best possible results of treatment of acquired cholesteatoma, we made a subdivision of cholesteatoma types into attic and pars tensa cholesteatomas, and subdivided the latter further into tensa retraction cholesteatoma and sinus cholesteatomas. Tensa retraction cholesteatoma is defined as arising from a retraction or perforation of the whole pars tensa, whereas sinus cholesteatoma is defined as arising from a retraction or perforation of the postero-superior part of the tensa. We present the long-term results obtained in tensa retraction cholesteatomas treated with one stage surgery from 1964 to 1980. Median observation time was 9 years, range 2 to 19 years. Sixty-one ears were treated without mastoidectomy, whereas 71 ears had canal wall-up mastoidectomy and 64 ears had canal wall-down mastoidectomy. The total recurrence rate was 13.3 per cent; 17 ears had residual cholesteatoma, and nine ears had recurrent cholesteatoma. The best results were obtained in ears with an intact ossicular chain where mastoidectomy was not performed. In 49 per cent of the cases, the cholesteatoma was confined to the tympanic cavity without reaching the aditus, antrum or mastoid process. About one-third to one-quarter of the ears had tympanoplasty only, with removal of the cholesteatoma through the ear canal.

Entities:  

Mesh:

Year:  1989        PMID: 2926259     DOI: 10.1017/s0022215100108321

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  6 in total

1.  Hearing outcome after sequential cholesteatoma surgery.

Authors:  Susen Lailach; Thomas Zahnert; Nikoloz Lasurashvili; Max Kemper; Thomas Beleites; Marcus Neudert
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-09-03       Impact factor: 2.503

Review 2.  Tympanic membrane retraction pocket staging: is it worthwhile?

Authors:  Musaed Alzahrani; Issam Saliba
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-27       Impact factor: 2.503

3.  Cholesteatoma in children. An Egyptian overview.

Authors:  A M Elrashidi
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

Review 4.  Updates and knowledge gaps in cholesteatoma research.

Authors:  Chin-Lung Kuo; An-Suey Shiao; Matthew Yung; Masafumi Sakagami; Holger Sudhoff; Chih-Hung Wang; Chyong-Hsin Hsu; Chiang-Feng Lien
Journal:  Biomed Res Int       Date:  2015-03-18       Impact factor: 3.411

Review 5.  Endoscopic Management of Pediatric Cholesteatoma.

Authors:  Peter J Ryan; Nirmal P Patel
Journal:  J Otol       Date:  2018-12-03

6.  Assessing the Prognostic Value of the ChOLE Classification in Predicting the Severity of Acquired Cholesteatoma.

Authors:  Maura C Eggink; Maarten J F de Wolf; Fenna A Ebbens; Frederik G Dikkers; Erik van Spronsen
Journal:  Otol Neurotol       Date:  2022-04-01       Impact factor: 2.311

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.